As companies race to develop the first fully-automated insulin delivery system, a group of tech-savvy patients are hacking their own artificial pancreas systems. And industry is just starting to take notice of this highly motivated grassroots movement.

“They want more choice. They want more freedom. And, essentially, they want it now,” JDRF research director Dan Finan told Drug Delivery Business News.

But, as Finan pointed out, people making DIY diabetes technology end up using devices that aren’t regulated or secure. That’s where the JDRF’s latest initiative comes into play.

Get the full story at our sister site, Drug Delivery Business News.